To view the PDF file, sign up for a MySharenet subscription.

MVG/MVGP - Mvelaphanda Group Limited - The Listing of Mvelaserve on the JSE

Release Date: 27/10/2010 07:52
Code(s): MVG MVGP
Wrap Text

MVG/MVGP - Mvelaphanda Group Limited - The Listing of Mvelaserve on the JSE Main Board and The Unbundling of Mvela Group Shares in Mvelaserve to Mvela Group Ordinary Shareholders Mvelaphanda Group Limited Registration Number: 1995/004153/06 (Incorporated in the Republic of South Africa) Ordinary share code: MVG ISIN: ZAE000060737 Preference share code: MVGP ISIN: ZAE000073540 ("Mvela Group" or "the Company") THE LISTING OF MVELASERVE ON THE JSE MAIN BOARD AND THE UNBUNDLING OF MVELA GROUP SHARES IN MVELASERVE TO MVELA GROUP ORDINARY SHAREHOLDERS 1 Introduction Mvela Group ordinary and preference shareholders ("Mvela Group shareholders") are referred to the announcement released on SENS on 7 October 2010, which confirmed the Mvela Group board of directors` ("Board") intention to proceed with the separate listing of the shares in Mvelaserve Limited ("Mvelaserve") and the subsequent unbundling of Mvela Group`s shares in Mvelaserve to Mvela Group ordinary shareholders ("the Unbundling"). The Board has therefore made application for the separate listing of Mvelaserve on the securities exchange operated by the JSE Limited ("JSE") ("Mvelaserve Listing"), and will distribute all of the Mvelaserve shares held by the Company to shareholders recorded on the register on Friday, 3 December 2010 (the "Record Date"), subject to the fulfilment of the conditions precedent as set out in paragraph 5 below. 2 Rationale for the Mvelaserve Listing and Unbundling The Mvela Group directors have undertaken an extensive strategic review of their investments and have concluded that it is preferable for Mvelaserve to be a separately listed, focused services business. The Mvelaserve Listing and subsequent Unbundling will enhance the strategic flexibility of the Mvelaserve business and will enable it to embark on its own strategy to grow both organically and by acquisition. In addition, the Mvelaserve Listing will provide a listed reference price for Mvelaserve and will allow investors to attribute appropriate share price ratings to both Mvela Group and Mvelaserve, aligned to the specific dynamics of each of the respective companies. 3 The Unbundling Subject to the fulfilment of the conditions precedent as set out in paragraph 5 below, Mvela Group will unbundle its 100% interest in Mvelaserve to Mvela Group ordinary shareholders. Mvela Group ordinary shareholders, including the Mvela Group treasury share entities, will receive Mvelaserve ordinary shares for Mvela Group ordinary shares held on the Record Date. The provisional entitlement ratio is 25 Mvelaserve ordinary shares for every 100 Mvela Group ordinary shares held on the Record Date, although this may change as a result of the conversion of Mvela Group preference shares into Mvela Group ordinary shares. The final entitlement ratio will be announced once the total number of preference shares who have elected to convert to ordinary shares is known. The Unbundling will be in terms of section 90 of the Companies Act, (Act 61 of 1973), as amended ("the Companies Act"), the relevant provisions of the Listings Requirements and section 46 of the Income Tax Act, (Act 58 of 1962), as amended ("Income Tax Act"). Furthermore, if it is determined that the Unbundling represents the whole or greater part of the Company`s assets or undertaking, the shareholders will be required to pass a special resolution in accordance with section 228 of the Companies Act. This special resolution will be withdrawn at the combined general meeting if the directors of the Company are satisfied that the Unbundling does not involve the whole or greater part of the Company`s assets or undertaking. The Unbundling will be implemented by way of a reduction of Mvela Group`s share premium account (as contemplated in the Companies Act) as at the Record Date and thereafter by reducing reserves to the extent necessary. 4 Restructuring Mvela Group and Mvelaserve have been restructured prior to the Mvelaserve Listing to achieve the following: * Zonke Monitoring Systems (Proprietary) Limited ("Zonke"): Mvela Group disposed of its 75% interest in Zonke to Mvelaserve. In terms of the Zonke sale and purchase agreement, effective on or about 7 October 2010, Mvelaserve allotted and issued 6,850,937 new Mvelaserve shares (after the Mvelaserve share split) to Mvela Group in exchange for Mvela Group;s shares in Macthyme Investments (Proprietary) Limited (a wholly owned subsidiary of Mvela Group) which had acquired Mvela Group;s 75% interest in Zonke from Mvelaphanda Strategic Investments (Proprietary) Limited (a wholly owned subisidary of Mvela Group). The acquisition was concluded at a value of R81 million for Mvela Group`s 75% interest. The new Mvelaserve shares issued to Mvela Group as consideration for Zonke will form part of the Unbundling and have been taken into account in the calculation of the provisional entitlement ratio. * Stamford Sales: Mvelaserve`s and Mvelaphanda Management Services` (a wholly owned subsidiary of Mvelaserve) jointly-held 40% interest in Stamford Sales was sold to Mvela Group at a value of R26 982 820 on loan account. * Settlement of intercompany loans between Mvelaserve group and Mvela Group: The intercompany loans between Mvelaserve group and Mvela Group have been settled through cash flows, set-offs, cession of loans and net-off journals, with R653 million due from Mvelaserve group to Mvela Group being settled through the issue of 55,254,736 new Mvelaserve shares (after the Mvelaserve share split of 794,559 new Mvelaserve shares for every 1 Mvelaserve share) to Mvela Group and the utilisation by Mvelaserve of the subscription price in respect of the aforesaid shares to settle the loan. These new Mvelaserve shares will form part of the Unbundling and have been taken into account in the calculation of the provisional entitlement ratio. 5 Conditions precedent The JSE has approved the Mvelaserve Listing subject to the fulfilment of the following conditions precedent: * the submission to the JSE of the relevant Part II documents as set out in Section 16 of the JSE Listings Requirements; * the passing by Mvela Group shareholders at the Mvela Group combined general meeting of the resolutions required to approve the Unbundling; and * the registration of any special resolution by the Companies and Intellectual Property Registration Office ("CIPRO"). The Unbundling is subject to the fulfilment of the following conditions precedent by no later than 15 December 2010: * the passing by Mvela Group shareholders at the Mvela Group combined general meeting of the resolutions required to approve the Unbundling; * the registration of any special resolution by CIPRO; and * the listing of the Mvelaserve shares on the JSE. 6 Salient dates and times The salient dates and times of the Mvelaserve Listing and Unbundling are as follows: 2010
Distribution of Mvelaserve pre-listing statement Wednesday, 27 October to Mvela Group shareholders on or about Publication of abridged pre-listing statement on Wednesday, 27 October SENS and in the South African press Publication of abridged pre-listing statement in Thursday, 28 October the South African press Last day for the receipt of forms of proxy for Wednesday, 17 November the combined general meeting by 10:00 Combined general meeting to be held at Melrose Thursday, 18 November Arch Hotel, High Street, Melrose Arch, Johannesburg at 10:00 Results of the combined general meeting released Thursday, 18 November on SENS Results of the combined general meeting Friday, 19 November published in the South African press Finalisation announcement, including Friday, 19 November confirmation of the entitlement ratio or adjustment to the provisional entitlement ratio released on SENS by no later than 4 Last day to trade in Mvela Group ordinary shares Friday, 26 November on the JSE to participate in the Unbundling Mvela Group ordinary shares trade "ex" their Monday, 29 November entitlement to unbundled Mvelaserve shares Mvelaserve ordinary shares listed on the JSE Monday, 29 November (the JSE share code will be MVS and the ISIN will be ZAE000151353) Mvela Group ordinary shareholders commence Monday, 29 November trading their unbundled Mvelaserve shares (the JSE share code will be MVS and the ISIN will be ZAE000151353) Unbundling record date Friday, 3 December Announcement of specified ratio in respect of Monday, 6 December the apportionment of the base cost to Mvelaserve for taxation/CGT purposes on or about Dematerialised Mvela Group ordinary shareholders Monday, 6 December will have their accounts with their CSDP or broker updated with the unbundled Mvelaserve shares on or about Share certificates in respect of the unbundled Monday, 6 December Mvelaserve shares will be posted, by registered post, at the risk of the certificated Mvela Group ordinary shareholders concerned, to certificated Mvela Group ordinary shareholders on or about Notes: 1 The above dates and times are subject to change. Any material changes will be released on SENS and published in the South African press. 2 All times quoted in this circular are local times in South Africa. 3 No dematerialisation or re-materialisation of Mvela Group ordinary share certificates may take place between Monday, 29 November 2010 and Friday, 3 December 2010, both days inclusive. 4 It is possible that as at the date of the general meeting of Mvela Group shareholders the Mvelaserve shares constitute the greater part of the assets of Mvela Group as contemplated in section 228 of the Companies Act. Should this be the case, a special resolution will be required to be passed by Mvela Group shareholders and subsequently lodged and registered by CIPRO. In this instance, the finalisation date announcement will be made as soon as possible following the registration of the special resolution by CIPRO, and the updated dates and times will be released on SENS and published in the South African press. 7 Pro forma financial effects Following the Unbundling, Mvela Group shareholders will hold the Mvelaserve shares directly and accordingly there will be no material effect on the aggregate earnings and underlying net asset value attributable to each shareholder. The table below sets out the pro forma financial effects of the Unbundling on Mvela Group`s audited earnings per share ("EPS"), headline earnings per share ("HEPS"), diluted EPS and diluted HEPS for the year ended 30 June 2010, as well as Mvela Group`s net asset value per ordinary share and net tangible asset value per ordinary share at 30 June 2010. These pro forma financial effects have been prepared for illustrative purposes only and, because of their nature, may not fairly present Mvela Group`s financial position, changes in equity, and results of operations or cash flows. The pro forma financial information is the responsibility of the Directors. The Health unbundling refers to the unbundling by Mvela Group to its ordinary shareholders of all of its shares held in Health Strategic Investments Limited ("Health"), an asset backed security listed on the JSE which owns the strategic investment in Life Healthcare Group Holdings Limited ("Life Healthcare") previously held by Mvela Group. Full details of the Health unbundling were disclosed in the circular to shareholders dated 28 June 2010. Before Effects Post Effect Post Effect Post Total (cents of the Health of Health of Health % ) Health Unbundl Zonke Unbundl Mvelase Unbundl change 1 Unbundli ing Sale ing and rve ing, ng (cents) (cents) Zonke Unbundl Zonke (cents) 7, 8, 11 Sale ing Sale 9, 10 (cents) (cents) and 12, 13, Mvelase
14, 15, rve 16 Unbundl ing (cents)
5 Earnings 212.7 (170.6) 42.1 (2.5) 39.6 160.9 200.5 -5.75% per ordinary share 2, 6 Headline 238.5 (170.6) 67.9 (2.5) 65.4 (38.1) 27.2 -88.58 earnings % per ordinary share 2, 6 Diluted 192.5 (149.2) 43.3 (2.2) 41.1 159.4 200.5 4.16% earnings per ordinary share 2, 6 Diluted 215.0 (149.2) 65.8 (2.2) 63.6 (36.4) 27.2 - headline 87.34% earnings per ordinary share 2, 6 NAV per 1 (437.3) 577.8 (6.7) 571.1 (213.2) 357.9 - ordinary 015.1 64.74% share 3 TNAV per 832.0 (437.3) 394.7 (6.7) 388.0 (69.9) 318.1 - ordinary 61.77% share 3
Diluted 465 465 484 465 484 527 599 number 484 of ordinary shares in issue (`000) 4 Diluted 465 465 307 465 307 527 422 weighted 307 number of ordinary shares in issue (`000) 4 Weighted 406 406 962 406 962 527 422 number 962 of ordinary shares (`000) 4 Notes and assumptions: 1 The Mvela Group financial information reflected in the "Before" column has been extracted from the published audited annual results of Mvela Group for the year ended 30 June 2010. 2 The pro forma adjustments to the statement of comprehensive income have been calculated on the assumption that the Health unbundling, Zonke sale and the Unbundling were implemented on 1 July 2009. 3 The pro forma adjustments to the statement of financial position have been calculated on the assumption that the Health unbundling, Zonke sale and the Unbundling were implemented on 30 June 2010. 4 Any conversion of Mvela Group preference shares into Mvela Group ordinary shares prior to the finalisation date of the transactions will have no impact on the financial effects as set out above, as the financial effects have been formulated on a fully diluted basis. 5 Preference dividends paid of R30 million have been added back to total comprehensive income attributable to ordinary shareholders in the statement of comprehensive income. 6 Assumed conversion of all of the Mvela Group preference shares in the ratio of 2.22 : 1, i.e. 120 460 000 new ordinary shares. The last conversion date for the preference shares to elect to convert into ordinary shares is 4 November 2010 per the Conversion Circular. 7 In the statement of comprehensive income all adjustments are considered to have a continuing effect, except for the adjustments detailed in notes 16 and 17. Notes relating to the Health unbundling 8 On 20 August 2010 Mvela Group distributed all of the shares held by it in Health, constituting 53.52% of the issued ordinary share capital of Health, to Mvela Group ordinary shareholders in terms of section 90 of the Companies Act and in accordance with section 46 of the Income Tax Act. Health owns the strategic investment in Life Healthcare previously held by Mvela Group. 9 Dividends received during the year ended 30 June 2010 on Life Healthcare shares unbundled have been deducted from previously reported earnings in the statement of comprehensive income. 10 The fair value adjustment for the year ended 30 June 2010 on the Life Healthcare shares unbundled has been reversed in the statement of comprehensive income. 11 Interest paid on debt associated with the Life Healthcare shares unbundled has been reversed in the statement of comprehensive income.
Notes relating to the Zonke sale 12 In October 2010 Mvela Group sold its 75% interest in Zonke for R81 million which was settled through the issue of 6,850,937 new Mvelaserve shares (after the Mvelaserve share split) to Mvela Group. No profit will arise on the Zonke sale as the sale takes place between group companies. Notes relating to the Mvelaserve Unbundling 13 The assets and liabilities, in the statement of financial position, and all transactions, in the statement of comprehensive income, relating to Mvelaserve, including any consolidation journal entries, have been reversed from the Mvela Group financial information. 14 The net settlement of the intercompany loan accounts between Mvela Group and Mvelaserve was settled through the issue of 55,254,736 new Mvelaserve shares to Mvela Group. 15 Net interest paid by Mvela Group on inter-company loan accounts with Mvelaserve and Zonke have been reversed to the statement of comprehensive income. 16 Profit on the unbundling of Mvelaserve of R957 million, being the difference between the carrying value of Mvelaserve in Mvela Group and the fair value of its assets less its liabilities at the date of the Unbundling. The carrying value of Mvelaserve in Mvela Group is R766 million and the fair value of its assets less its liabilities has been determined at R1,723 billion for purposes of this calculation. 17 Transaction costs of R3.94m which are non-deductible for income tax purposes have been expensed to the statement of comprehensive income. 8 Directors` opinion and recommendation The Board has considered the terms and conditions of the Unbundling and are of the opinion that the Unbundling will enhance shareholder value for Mvela Group shareholders. Accordingly, the directors of Mvela Group are in favour of the Unbundling and intend to vote, in respect of any Mvela Group shares held by them at the date of the general meeting, in favour of the resolutions necessary to approve and implement the Unbundling. Furthermore, the Board recommends that shareholders also vote in favour of such resolutions. 9 General meeting A combined general meeting of Mvela Group shareholders will be held at Melrose Arch Hotel, High Street, Melrose Arch, Johannesburg, at 10:00 on Thursday, 18 November 2010 to consider, and if deemed fit, to pass, with or without modification, the special and ordinary resolutions required to implement the Unbundling. 10 Circular to shareholders A circular, including the notice convening the general meeting, together with the Mvelaserve pre-listing statement, will be posted to shareholders on or about Wednesday, 27 October 2010. Copies of these documents may be obtained during normal business hours from Wednesday, 27 October 2010 until Thursday, 18 November 2010 at the registered office of Mvela Group. Johannesburg 27 October 2010 Corporate adviser and transaction sponsor to Mvela Group and Mvelaserve Limited Investec Bank Limited Legal adviser to Mvela Group and Mvelaserve Limited Cliffe Dekker Hofmeyr Inc Sponsor to Mvela Group Deutsche Securities (SA) (Proprietary) Limited Reporting accountants and auditors PKF (Jhb) Inc Communications advisers College Hill Date: 27/10/2010 07:52:02 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.